0001127602-19-018976.txt : 20190517
0001127602-19-018976.hdr.sgml : 20190517
20190517160750
ACCESSION NUMBER: 0001127602-19-018976
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20190515
FILED AS OF DATE: 20190517
DATE AS OF CHANGE: 20190517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lemoine David A
CENTRAL INDEX KEY: 0001501185
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33462
FILM NUMBER: 19835700
MAIL ADDRESS:
STREET 1: C/O THE L S STARRETT COMPANY
STREET 2: 121 CRESCENT STREET
CITY: ATHOL
STATE: MA
ZIP: 01331
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INSULET CORP
CENTRAL INDEX KEY: 0001145197
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 043523891
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
BUSINESS PHONE: 978-600-7000
MAIL ADDRESS:
STREET 1: 100 NAGOG PARK
CITY: ACTON
STATE: MA
ZIP: 01720
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2019-05-15
0001145197
INSULET CORP
PODD
0001501185
Lemoine David A
C/O INSULET CORPORATION
100 NAGOG PARK
ACTON
MA
01720
1
Common Stock
2019-05-15
4
S
0
874
102.49
D
9148
D
Common Stock
2019-05-16
4
M
0
8752
26.00
A
17900
D
Common Stock
2019-05-16
4
S
0
8752
106.9192
D
9148
D
Stock Option (Right to Buy)
26.00
2019-05-16
4
M
0
8752
0
D
2026-02-09
Common Stock
8752
0
D
This transaction represents the sale of shares intended to approximate the associated tax liability resulting from the vesting of restricted stock units on April 30, 2019.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2019.
The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $106.89 to $107.105. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
This option is subject to a three year vesting period with one-half of the total award vesting on February 9, 2017, one-quarter of the total award vesting on February 9, 2018 and one-quarter of the total award vesting on February 9, 2019, subject to continued service as a director or consultant.
/s/ John W. Kapples, attorney-in-fact
2019-05-17
EX-24
2
doc1.txt
POWER OF ATTORNEY (PUBLIC): POA
POWER OF ATTORNEY
KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby
constitutes and appoints Shacey Petrovic, John W. Kapples, Wayde D.
McMillan and Keith Bilezerian, and any one of them acting singly, the
true and lawful attorneys-in-fact and agents, with full power of
substitution and resubstitution, for the undersigned and in the
undersigned's name, place and stead, in any and all capacities (until
revoked in writing) to execute for and on behalf of the undersigned, in any
any and all of the undersigned's capacities any and all statements on
Forms 3, 4 and 5 with respect to the undersigned's holdings of and
transactions in securities issued by Insulet Corporation (the "Company")
in accordance with Sections 16(a) of the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), and any and all regulations promulgated
thereunder, and to file the same, with all exhibits thereto, and any other
documents in connection therewith, with the Securities and Exchange
Commission, and with any other entity when and if such is mandated by the
Exchange Act or by the By-laws of the National Association of Securities
Dealers, granting unto said attorneys-in-fact and agents full power and
authority to do and perform each and every act and thing requisite and
necessary fully to all intents and purposes as the undersigned might or
could do in person thereby ratifying and confirming all that said
attorneys-in-fact and agents, or their substitute or substitutes, may lawfully
do or cause to be done by virtue hereof.
This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4 and 5 with respect to
the undersigned's holdings of and transactions in securities issued by the
Company, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.
IN WITNESS WHEREOF, this Power of Attorney has been signed as of
March 26, 2019.
Signature: /s/ David A. Lemoine
Name: David A. Lemoine